Aixial
Aixial is recorded as a service provider in 4 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 4 of 4 trials · Latest update first
ADVANCE: A Phase III Multi-Centre, Randomised, Double-Blind, Double-Dummy Clinical Trial Comparing Essentiale® Liquid vs. Capsules for MASLD/MASH, Alcoholic Liver Disease, and Chronic Viral Hepatitis B
Sponsor Opella Healthcare Group S.A.S.
- Start (EU)
- Latest update
- Estimated end
- Not reported
A randomized, subject and investigator blinded, placebo controlled and multi-center platform study, to assess efficacy and safety of different investigational drugs in patients with moderate to severe hidradenitis suppurativa
Sponsor Novartis Pharma AG
- Start (EU)
- Latest update
- Estimated end
PEITHO-3 - A reduced dose of thrombolytic treatment for patients with intermediate high-risk acute pulmonary embolism: a randomized controlled trial
Sponsor Assistance Publique Hopitaux De Paris
- Start (EU)
- Latest update
- Estimated end
A Phase I/II, Multicenter, Non-randomized, Open Label, Adaptive Design, 5-year Follow-up, Single Dose-escalation Study of VTX-801 in Adult Patients with Wilson's Disease
Sponsor Vivet Therapeutics
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for Aixial?
The 2026-10-09 snapshot links Aixial to 4 distinct CTIS trials. Recorded services include Clinical monitoring, Interactive response technology (IRT), Project management, Regulatory services, among 13 recorded service labels. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Aixial?
The most frequently recorded therapeutic areas are Dermatology, Gastroenterology, Hepatology, Infectious Disease. Recorded phases include Phase 2, Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Aixial conducted?
The linked trials record locations in 12 countries, including Germany, Austria, Spain, France, Poland. These are trial locations, not confirmed office locations or countries where Aixial delivered services.
What can this page tell me about Aixial's trial experience?
Browse 4 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Aixial. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Aixial